Bausch & Lomb Corp

Bausch & Lomb Corp (BLCO) priced its initial public offering on May 6, 2022 at $18.00 per share, below its $21.00–$24.00 range, raising $630M, and listed on NYSE. At the IPO price its market capitalization was about $6.3B. Morgan Stanley was lead-left underwriter, joined by Goldman Sachs, Citigroup and J.P. Morgan and others. Davis Polk, Sidley Austin, Osler and Davies Ward Phillips & Vineberg advised the underwriters.

Bausch & Lomb Corp is a global eye health company with a portfolio of over 400 products serving eye health needs across a person's life. It has a history of nearly 170 years and operates research, development and manufacturing facilities worldwide.

Status

IPO

Ticker

BLCO

Exchange

NYSE

Priced

May 6, 2022

IPO price

$18.00

Price range

$21.00–$24.00

Raised

$630M

Market cap at IPO price

$6.3B

First filed

Jan 13, 2022

Underwriters

Morgan Stanley, Goldman Sachs, Citigroup, J.P. Morgan, Barclays, BofA Securities, Guggenheim, Jefferies, Evercore ISI, Wells Fargo, Deutsche Bank and HSBC

Underwriters' counsel

Davis Polk, Sidley Austin, Osler and Davies Ward Phillips & Vineberg

Sector

Healthcare

Country / state

Ontario, Canada

Market cap at IPO price = shares outstanding after the offering (all classes, before the over-allotment option) × the IPO price, from the final prospectus.